Patients with cardiogenic shock are not all the same. They present with a variety of hemodynamic profiles and other features that may allow us to create specific phenotypes. It is possible that phenotyping these patients at presentation may then help us to identify the optimal and earliest therapies that will improve outcomes and, at the same time, help us to overcome some of the heterogeneity currently undermining clinical trials.
"Hemodynamic Variations in Cardiogenic Shock Phenotypes,"
Journal of Shock and Hemodynamics: Vol. 1(1)
Available at: https://digitalcommons.library.tmc.edu/josh/vol1/iss1/15